Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis

Lorena Lorefice(University of Cagliari), Eleonora Cocco(University of Cagliari)

Frontiers in Genetics

January 30, 2023

10.3389/fgene.2023.1076421

Cited by 16

Related Papers

Multiple Sclerosis Severity Score

|Neurology|2005|957

Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study

|Brain|2022|158

Assessing response to interferon-β in a multicenter dataset of patients with MS

|Neurology|2016|135

The Relationships between Physical Activity, Self-Efficacy, and Quality of Life in People with Multiple Sclerosis

|Behavioral Sciences|2019|34

Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis

|NeuroImage Clinical|2024|13